New eye patch boosts healing for serious corneal infections
NCT ID NCT07559149
First seen May 02, 2026 · Last updated May 18, 2026 · Updated 4 times
Summary
This study tested a special amniotic membrane containing riboflavin and moxifloxacin as an add-on treatment for people with moderate-to-severe infected corneal ulcers. The membrane was used during a light-activated therapy called PACK-CXL. Researchers compared this new approach to standard PACK-CXL alone in 32 adults to see if it speeds up healing and reduces inflammation. The goal is to improve recovery from serious eye infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTED CORNEAL ULCERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Sardjito General Hospital
Sleman, Special Region of Yogyakarta, 55281, Indonesia
Conditions
Explore the condition pages connected to this study.